Clinical trial
Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer
NCT02506114
Study timeline
Study start (actual)2016-10-06Date precision: day
Registry last updated2021-11-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostatic Neoplasmsunresolved
Interventions
PROSTVAC V/FBIOLOGICAL
IpilimumabDRUG · verified · RxNorm: ipilimumab
Sponsors & collaborators
Lawrence Fonglead sponsor
Bavarian Nordiccollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02506114 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.